AI and MR show strong potential in improving sarcoma management, particularly for diagnostic accuracy and surgical planning. However, the literature remains heterogeneous, consisting mostly of preliminary studies with limited statistical power. Large-scale multicenter studies are required to validate the impact of AI and MR on outcomes and safely integrate these technologies into routine care.
Joshi et al. (Thu,) studied this question.